{"id":1372,"date":"2021-03-31T00:00:00","date_gmt":"2021-03-30T22:00:00","guid":{"rendered":"https:\/\/preprod.retinegallien.com\/publication\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\/"},"modified":"2021-03-31T00:00:00","modified_gmt":"2021-03-30T22:00:00","slug":"one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema","status":"publish","type":"publication","link":"https:\/\/www.retinegallien.com\/en\/publication\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\/","title":{"rendered":"One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema"},"content":{"rendered":"<p>Thi Ha Chau T, Erginay A, Verdun S, <strong>Fourmaux E<\/strong>, Le Rouic JF, Uzzan J, Milazzo S, Baillif S, Kodjikian L.<br \/>\n<strong>Clinical Ophthalmology 2021:15 1-8<\/strong><br \/><\/br \/><\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"class_list":["post-1372","publication","type-publication","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema - R\u00e9tine Gallien<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.retinegallien.com\/en\/publication\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema - R\u00e9tine Gallien\" \/>\n<meta property=\"og:description\" content=\"Thi Ha Chau T, Erginay A, Verdun S, Fourmaux E, Le Rouic JF, Uzzan J, Milazzo S, Baillif S, Kodjikian L. Clinical Ophthalmology 2021:15 1-8\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.retinegallien.com\/en\/publication\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\/\" \/>\n<meta property=\"og:site_name\" content=\"R\u00e9tine Gallien\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\\\/\",\"url\":\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\\\/\",\"name\":\"One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema - R\u00e9tine Gallien\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#website\"},\"datePublished\":\"2021-03-30T22:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\",\"item\":\"https:\\\/\\\/www.retinegallien.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#website\",\"url\":\"https:\\\/\\\/www.retinegallien.com\\\/\",\"name\":\"R\u00e9tine Gallien\",\"description\":\"Cabinet Ophtalmologie \u00e0 Bordeaux\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.retinegallien.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#organization\",\"name\":\"R\u00e9tine Gallien\",\"url\":\"https:\\\/\\\/www.retinegallien.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.retinegallien.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.retinegallien.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/logo.png\",\"width\":322,\"height\":161,\"caption\":\"R\u00e9tine Gallien\"},\"image\":{\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema - R\u00e9tine Gallien","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.retinegallien.com\/en\/publication\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\/","og_locale":"en_US","og_type":"article","og_title":"One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema - R\u00e9tine Gallien","og_description":"Thi Ha Chau T, Erginay A, Verdun S, Fourmaux E, Le Rouic JF, Uzzan J, Milazzo S, Baillif S, Kodjikian L. Clinical Ophthalmology 2021:15 1-8","og_url":"https:\/\/www.retinegallien.com\/en\/publication\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\/","og_site_name":"R\u00e9tine Gallien","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.retinegallien.com\/en\/publication\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\/","url":"https:\/\/www.retinegallien.com\/en\/publication\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\/","name":"One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema - R\u00e9tine Gallien","isPartOf":{"@id":"https:\/\/www.retinegallien.com\/#website"},"datePublished":"2021-03-30T22:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.retinegallien.com\/en\/publication\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.retinegallien.com\/en\/publication\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.retinegallien.com\/en\/publication\/one-year-outcome-of-aflibercept-intravitreal-injection-in-vitrectomized-eyes-with-diabetic-macular-edema\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"","item":"https:\/\/www.retinegallien.com\/"},{"@type":"ListItem","position":2,"name":"One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema"}]},{"@type":"WebSite","@id":"https:\/\/www.retinegallien.com\/#website","url":"https:\/\/www.retinegallien.com\/","name":"R\u00e9tine Gallien","description":"Cabinet Ophtalmologie \u00e0 Bordeaux","publisher":{"@id":"https:\/\/www.retinegallien.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.retinegallien.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.retinegallien.com\/#organization","name":"R\u00e9tine Gallien","url":"https:\/\/www.retinegallien.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.retinegallien.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.retinegallien.com\/wp-content\/uploads\/2024\/12\/logo.png","contentUrl":"https:\/\/www.retinegallien.com\/wp-content\/uploads\/2024\/12\/logo.png","width":322,"height":161,"caption":"R\u00e9tine Gallien"},"image":{"@id":"https:\/\/www.retinegallien.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.retinegallien.com\/en\/wp-json\/wp\/v2\/publication\/1372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.retinegallien.com\/en\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/www.retinegallien.com\/en\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/www.retinegallien.com\/en\/wp-json\/wp\/v2\/media?parent=1372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}